Healthcare - Sector
EDIT is currently covered by 4 analysts with an average price target of $7.5. This is a potential upside of $5.86 (357.32%) from yesterday's end of day stock price of $1.64.
Editas Medicine's activity chart (see below) currently has 164 price targets and 151 ratings on display. The stock rating distribution of EDIT is 66.67% BUY and 33.33% HOLD.
Analysts' price targets on this stock were met 43.6% of the time, taking 112.64 days on average.
Highest price target for EDIT is $15, Lowest price target is $4, average price target is $7.5.
Most recent stock forecast was given by YANAN ZHU from WELLS FARGO on 08-Oct-2026. First documented stock forecast 28-Feb-2016.
Currently out of the existing stock ratings of EDIT, 4 are a BUY (66.67%), 2 are a HOLD (33.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 03-Sep-2025
$6
$4.36 (265.85%)
$4
1 months 13 days ago
(08-Oct-2026)
3/9 (33.33%)
$3.16 (111.27%)
45
Buy Since 10-Apr-2026
$15
$13.36 (814.63%)
$15
5 months 25 days ago
(27-May-2026)
0/2 (0%)
$11.43 (320.17%)
Buy Since 03-Apr-2019
$4
$1.15 (40.35%)
$3.5
6 months 16 days ago
(05-May-2026)
2/11 (18.18%)
$0.96 (31.58%)
330
Hold Since 10-Mar-2026
$8
$5.15 (180.70%)
$13
8 months 11 days ago
(10-Mar-2026)
0/2 (0%)
$5.36 (203.03%)
Buy Since 18-Dec-2024
$4.6
$4
1 years 11 days ago
(10-Nov-2025)
1/2 (50%)
$2.08 (82.54%)
294
What is EDIT (Editas Medicine) average time for price targets to be met?
Which analyst most recently updated their price target on EDIT (Editas Medicine)?
Which analyst has the most public recommendations on EDIT (Editas Medicine)?
Which analyst is the currently most bullish on EDIT (Editas Medicine)?
Which analyst is the currently most reserved on EDIT (Editas Medicine)?